trial

Integrated Care in Psychotic Disorders With Severe Mental Illness

NCTId NCT01888627

as of 2026-07-01

Add to landscape Monitor this Ask about this

at a glance

— · Unknown

Enrollment 400 (estimated)

Sponsored by Universitätsklinikum Hamburg-Eppendorf

Primary completion 2025-01

Synthesized from structured facts only — each point cited above.

Design & status

Phase

—

Status

Unknown

Enrollment

400 (estimated)

Study type

Interventional

Allocation

Model

Single Group

Masking

None

Start

2007-05

Primary completion

2025-01

Eligibility

ALL · 12 Years

Interventions & indications

Drugs

Integrated care

Indications

Bipolar Disorder Schizophreniform Disorder Schizoaffective Disorder Psychotic Disorder NOS Severe Major Depression With Psychotic Features Schizophrenia, Paranoid Psychotic Disorders Schizophrenia Bipolar Disorder Schizophrenia Delusional Disorder Mental Disorders

Investigators

Martin Lambert, ProfessorPrincipal Investigator

Sites

1 total

Hamburg, Germany

Facts & assertions

4 sourced

Enrollment

400

Phase

Primary Completion Date

2025-01

Status

UNKNOWN

relationships

The graph out of here

drug

Integrated care

drug

lead_sponsor

Universitätsklinikum Hamburg-Eppendorf

company

indication

Bipolar Disorder

indication

Schizophreniform Disorder

indication

Schizoaffective Disorder

indication

investigator

Martin Lambert, Professor

person